メタ情報
| meta description平均長 | 439.32 |
|---|
| OGPありページ数 | 51 |
|---|
| Twitterカードありページ数 | 51 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 54 |
|---|
| ページあたり内部リンク平均 | 48.37 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| you | 1 |
| shall | 0.851025 |
| arbitration | 0.851025 |
| any | 0.825777 |
| Arbitration | 0.709188 |
| relapse | 0.701935 |
| your | 0.62423 |
| haploidentical | 0.607632 |
| matched | 0.606282 |
| Company | 0.605657 |
| YOU | 0.602809 |
| leukemia | 0.587531 |
| study | 0.577335 |
| Services | 0.576816 |
| cells | 0.576595 |
| transplant | 0.574062 |
| survival | 0.568912 |
| use | 0.565863 |
| acute | 0.562186 |
| donors | 0.559354 |
| GvHD | 0.550228 |
| not | 0.50887 |
| PTCy | 0.50636 |
| Phase | 0.500707 |
| will | 0.499401 |
| outcomes | 0.499268 |
| Agreement | 0.496431 |
| award | 0.496431 |
| information | 0.489952 |
| Title | 0.477806 |
| was | 0.476208 |
| Session | 0.472603 |
| free | 0.461705 |
| arbitrator | 0.460972 |
| rates | 0.460645 |
| alloHSCT | 0.460645 |
| stem | 0.449983 |
| blood | 0.443064 |
| were | 0.441184 |
| data | 0.439756 |
| Allogeneic | 0.438846 |
| across | 0.437122 |
| may | 0.434369 |
| party | 0.432612 |
| Terms | 0.425513 |
| NOT | 0.425513 |
| risk | 0.422298 |
| other | 0.421298 |
| standard | 0.418616 |
| potential | 0.418616 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| com | orcabio | 5.257794 | 453 |
| high | precision | 4.994565 | 561 |
| biotechnology | stage | 4.971602 | 284 |
| late | stage | 4.83442 | 256 |
| autoimmune | diseases | 4.800612 | 239 |
| biotechnology | company | 4.695115 | 292 |
| What | Who | 4.678714 | 140 |
| acute | leukemia | 4.580483 | 266 |
| host | versus | 4.563998 | 182 |
| MENLO | PARK | 4.539728 | 144 |
| graft | versus | 4.531596 | 180 |
| Communications | Corporate | 4.528506 | 144 |
| Investor | Relations | 4.528506 | 144 |
| Joshua | Relations | 4.528506 | 144 |
| Join | Programs | 4.505572 | 140 |
| Newsroom | Team | 4.505572 | 140 |
| Joshua | Murray | 4.500988 | 144 |
| care | standard | 4.4853 | 196 |
| disease | host | 4.484802 | 188 |
| Grossman | Kelsey | 4.351204 | 116 |
| company | developing | 4.3244 | 243 |
| MENLO | Newsroom | 4.244301 | 128 |
| Annual | Meeting | 4.194957 | 114 |
| Clinical | Programs | 4.171436 | 140 |
| American | Society | 4.159019 | 96 |
| Communications | Kelsey | 4.152092 | 116 |
| Grossman | media | 4.152092 | 116 |
| announced | today | 4.136778 | 128 |
| Drug | Food | 4.099194 | 100 |
| Administration | Drug | 4.099194 | 100 |
| Date | Time | 4.078059 | 104 |
| visit | www | 4.074049 | 144 |
| autoimmune | cancer | 4.065238 | 200 |
| hematologic | malignancies | 4.04325 | 152 |
| information | visit | 4.025554 | 144 |
| Bio | Orca | 4.013442 | 1271 |
| graft | host | 4.011007 | 145 |
| Abstract | Number | 3.997275 | 76 |
| dramatically | fewer | 3.9612 | 100 |
| Dimov | Ivan | 3.951461 | 72 |
| center | multi | 3.926624 | 92 |
| disorders | genetic | 3.904524 | 138 |
| biotechnology | late | 3.889401 | 189 |
| RMAT | designation | 3.883441 | 76 |
| defined | uniquely | 3.879735 | 76 |
| Medicine | Regenerative | 3.876422 | 88 |
| acute | myeloid | 3.849982 | 152 |
| Our | Programs | 3.843063 | 175 |
| Join | Our | 3.843063 | 175 |
| fewer | risks | 3.823609 | 120 |